Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Lawrence Insider Profile
4 Followers
David Lawrence, Chief, Bus. Ops & PAO at Acorda Therapeutics, holds 14.95K shares in Acorda Therapeutics (Ticker: ACORQ).
David Lawrence has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of David Lawrence's holdings
Insider Roles
Chief, Bus. Ops & PAO
Roles that David Lawrence holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Feb 25, 2019 - Feb 25, 2020
Return:+89.70%
The most profitable trade made by David Lawrence
David Lawrence's Trading History
List of latest transactions for each holding click on a transaction to see David Lawrence's performance on stock
You May Also Like
David Lawrence insider profile FAQ
What is the percentage of profitable transactions made by David Lawrence?
The percentage of profitable transactions made by David Lawrence is ―.
What is the average return per transaction made by David Lawrence?
The average return per transaction made by David Lawrence is ―.
What stocks does David Lawrence hold?
David Lawrence holds: ACORQ stocks.
What was David Lawrence’s latest transaction?
David Lawrence latest transaction was an Uninformative Sell of $870.40.
What was David Lawrence's most profitable transaction?
David Lawrence’s most profitable transaction was an Informative Sell of ACORQ stock on February 25, 2019. The return on the trade was 89.70%.
What is David Lawrence's role in Acorda Therapeutics?
David Lawrence's role in Acorda Therapeutics is Chief, Bus. Ops & PAO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.